Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × 1-methyltryptophan × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 2 Glioblastoma 2 Ependymoma 2 Brain Neoplasms 2 Neuroectodermal Tumors, Primitive 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Cyclophosphamide 3 fludarabine 2 Temozolomide 2 Eflornithine 2 ibrutinib 1 gallium Ga 68 dotatate 1 Standard of Care 1 Radiotherapy 1 Etoposide 1 Drug Therapy 1 CLR1404 1 Blood Specimen Collection 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05106296 2026-01-09

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Augusta University

Phase 1 Recruiting

Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡